Clinical Trials on Hematological Malignancy

Total 19118 results

Amsterdam UMC, location VUmc
ZonMw: The Netherlands Organisation for Health Research and Development; Fo...

Completed

Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO (SHORT)

Febrile Neutropenia | Hematological Malignancy

Netherlands
University Hospital, Brest

Completed

Early Antibiotic Discontinuation in FUO (ANTIBIOSTOP)

Febrile Neutropenia | Hematological Malignancy

France
Monash University

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension (RATIONALISE)

Hypogammaglobulinemia | Haematological Malignancy

Australia
Wyeth is now a wholly owned subsidiary of Pfizer
PETHEMA (Program for the Study and Treatment of Haematological Malignances)

Completed

Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients

Lymphoma | Leukemia | Stem Cell Transplantation | Myelodysplasia | Myeloma | Hematological Malignancy

Spain
University Hospital, Bordeaux

Completed

Transplantation of Ex-vivo Expanded Cord Blood Stems Cells (GRAPA)

Malignant Haematological Disease

France
Memorial Sloan Kettering Cancer Center

Completed

Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation

Lymphoma | Acute Myeloid Leukemia | Leukemia | Myelodysplastic Syndrome | Myeloma | Hematological Malignancy

United States
M.D. Anderson Cancer Center

Active, not recruiting

Distress Associated With Coronavirus Disease 2019 and Telehealth on Supportive Care Patients With Advanced Cancer

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | COVID-19 Infection | Recurrent Hematologic Malignancy

United States
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy

Hematologic Malignancy

China
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study Evaluating the Safety, Tolerability and Preliminary Efficacy of IBI322 in Subjects With Hematologic Malignancy

Hematologic Malignancy

China
Massachusetts General Hospital

Recruiting

Evaluation of PET/MRI in Children With Cancer

Hematologic Malignancy

United States
Center for International Blood and Marrow Transplant...
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Completed

Composite Health Assessment Risk Model (CHARM) for Older Adults (BMT CTN 1704) (BMT CTN 1704)

Hematologic Malignancy

United States
Rigshospitalet, Denmark
Novo Nordisk A/S

Completed

Symptom Identification and Management in Patients With Hematological Malignancy During Follow-up Care (SIMPly-CARE)

Hematologic Malignancy

Denmark
SecuraBio

Completed

A Long-term, Continued Treatment and Follow-up Study in Participants With Hematologic Malignancies Treated With Duvelisib (IPI-145)

Hematologic Malignancy

United States, Italy
Duke University

Active, not recruiting

A Research Program Targeting Pre- and Peri-transplant Optimization Program (R-PPOP)

Hematologic Malignancy

United States
St. Petersburg State Pavlov Medical University

Completed

Effects of Parenteral Nutrition in HSCT

Hematologic Malignancy

Russian Federation
Abramson Cancer Center of the University of Pennsylvania

Completed

Phase II Maraviroc for GVHD Prevention

Hematologic Malignancy

United States
Nantes University Hospital

Completed

Study of a Reduced-toxicity Myeloablative Conditioning Regimen Using Fludarabine and Full Doses of Intravenous Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens (FB4-PEDIA)

Hematologic Malignancy

France
Seoul National University Hospital
The Korean Society of Blood and Marrow Transplantation

Unknown

Phase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult Patients

Hematologic Malignancy
Istituto Clinico Humanitas

Terminated

Observational Study in Patients Who Underwent an Haploidentical Transplantation With T-repleted Bone Marrow

Hematologic Malignancy

Italy
Brigham and Women's Hospital
Dana-Farber Cancer Institute; Robert Wood Johnson Foundation; American Society...

Recruiting

A Positive Psychology Based Intervention (PATH-C) for Caregivers of HSCT Survivors (PATH-C)

Hematologic Malignancy

United States
Peking University People's Hospital

Recruiting

ATG Plus Low-dose PT-Cy for GVHD Prevention

Hematologic Malignancy

China
Prolacta Bioscience

Recruiting

Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation

Hematologic Malignancy

United States
Dana-Farber Cancer Institute

Recruiting

Home Transfusion for HEME

Hematologic Malignancy

United States
Northside Hospital, Inc.

Recruiting

Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation

Hematologic Malignancy

United States
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

B-Cell Reconstitution After Hematopoietic Stem Cell Transplantation (B-REC)

Hematologic Malignancy
St. Petersburg State Pavlov Medical University

Active, not recruiting

Risk-adapted Donor Lymphocyte Infusion After Allo-HSCT in Children With Hematologic Malignancy

Hematologic Malignancy

Russian Federation
Exact Sciences Corporation

Terminated

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies

Hematologic Malignancy

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

Hematologic Malignancy

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Withdrawn

Reiki as a Complementary Therapy: A Pilot Study

Hematologic Malignancy

United States
Istituto Clinico Humanitas

Completed

Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002).

Infection | Graft Vs Host Disease | Hematological Malignancy | Bone Marrow Transplant Complications | Bone Marrow Transplant Infection

Italy
University Hospital Tuebingen

Recruiting

CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT (CD45RADLIHaplo)

Hematologic Malignancy

Germany
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Recruiting

Molecular-genetic Characterization in Patients Undergoing CAR-T Cell Infusion (CAR_22)

Hematologic Malignancy

Italy
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects

Hematologic Malignancy

China
Duke University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Recruiting

Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies

Hematologic Malignancy

United States
NYU Langone Health

Active, not recruiting

A Phase II Single-arm Study of Total Body Irradiation With Linac Based VMAT and IGRT

Hematologic Malignancy

United States
Memorial Sloan Kettering Cancer Center

Completed

Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor

Hematologic Malignancy

United States
Garcia, Jose M., MD, PhD

Active, not recruiting

Patient Fitness and Body Composition During Hematopoietic Stem Cell Transplantation

Hematologic Malignancy

United States
Duke University

Completed

Mindfulness and CBT for Sleep

Hematologic Malignancy

United States
Maisonneuve-Rosemont Hospital
Canadian Institutes of Health Research (CIHR); Hopital de l'Enfant-Jesus; St.... and other collaborators

Completed

Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant

Hematologic Malignancy

Canada
Massachusetts General Hospital

Completed

Non Invasive Optical Imaging of WBC Count

Hematologic Malignancy

United States
Alberta Health services

Unknown

Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study

Hematologic Malignancy

Canada
Beckman Coulter, Inc.
The First Affiliated Hospital with Nanjing Medical University; Tongji Hospital and other collaborators

Recruiting

Evaluation of ClearLLab LS Screening Panel

Hematologic Diseases | Hematologic Neoplasms | Hematologic Malignancy

China
Nantes University Hospital
For Ever Fabien

Recruiting

Using of Virtual Reality to Relieve Procedural Pain in Pediatric Oncology. (VIRTUOSO)

Child, Only | Hematologic Malignancy | Hematologic Non Malignancy | Solid Tumor, Childhood

France
A.O. Ospedale Papa Giovanni XXIII

Recruiting

Infusion of Donor Derived Cytokine Induced Killer (CIK) Cells in Hematological Patients Relapsed After Haploidentical Stem Cell Transplant (Haplo-CIK)

Relapsed Hematologic Malignancy

Italy
Dana-Farber Cancer Institute

Recruiting

Proof-of-Concept Trial of a Positive Psychology Intervention for Caregivers of HSCT Patients (PATH-C)

Hematologic Malignancy | Caregiver

United States
Medical College of Wisconsin

Recruiting

Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation

Multiple Myeloma | Hematological Malignancy

United States
St. Jude Children's Research Hospital

Not yet recruiting

CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies

Lymphoma | Hematologic Malignancy | MDS | AML, Childhood | ALL, Childhood

United States
Firas El Chaer, MD

Recruiting

A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients (SuppCare 001)

Hematologic Malignancy | Platelet Refractoriness

United States
Northside Hospital, Inc.

Recruiting

GM-CSF With Post-Transplant Cyclophosphamide

Transplant-Related Hematologic Malignancy

United States
Dialectic Therapeutics, Inc

Completed

A Study of DT2216 in Relapsed/Refractory Malignancies

Solid Tumor | Hematologic Malignancy

United States

Clinical Trials on Hematological Malignancy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations